British Columbia Investment Management’s Medline Inc MDLN Stock Holding History

British Columbia Investment Management’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.18M	Buy	+55,378	New	+$2.23M	0.01%	585

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

British Columbia Investment Management's MDLN Position: Q2 2026 in Review

British Columbia Investment Management opened a new position in Medline Inc (MDLN) in Q2 2026: 55,378 shares worth $2.18M. The stake represents 0.01% of the portfolio and ranks #585 among its holdings.

405 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

British Columbia Investment Management held 55,378 shares of Medline Inc worth $2.18M as of Q2 2026.
Medline Inc was a new British Columbia Investment Management position in Q2 2026.
Medline Inc made up 0.01% of British Columbia Investment Management's portfolio in Q2 2026, its #585 holding.
405 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on British Columbia Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.